Abstract
Recovery from traumatic brain injury (TBI) is variable despite similarities in the severity or mechanism of injury. The study of genetic polymorphisms offers an avenue for explaining individual differences in recovery and outcome following TBI. The current paper reviews the role that genetic polymorphisms may play in influencing recovery and quality of life following TBI. Investigating the role of polymorphisms on recovery from TBI may contribute to a better understanding of individual variations in outcome and has the potential to lead to earlier and more targeted interventions and rehabilitation based on a patient’s genetic makeup. By outlining what has been discovered about the relationship between polymorphisms and TBI we hope to both inform the medical community about the potential for polymorphisms to influence recovery following TBI and provide a roadmap to researchers about the gaps in research within this population.
Keywords: Traumatic Brain Injury, Polymorphisms, Genes.
Current Pharmaceutical Design
Title:Neurobiological Influences on Recovery from Traumatic Brain Injury: The Role of Genetic Polymorphisms
Volume: 20 Issue: 26
Author(s): Starla M. Weaver and Jaclyn N. Portelli
Affiliation:
Keywords: Traumatic Brain Injury, Polymorphisms, Genes.
Abstract: Recovery from traumatic brain injury (TBI) is variable despite similarities in the severity or mechanism of injury. The study of genetic polymorphisms offers an avenue for explaining individual differences in recovery and outcome following TBI. The current paper reviews the role that genetic polymorphisms may play in influencing recovery and quality of life following TBI. Investigating the role of polymorphisms on recovery from TBI may contribute to a better understanding of individual variations in outcome and has the potential to lead to earlier and more targeted interventions and rehabilitation based on a patient’s genetic makeup. By outlining what has been discovered about the relationship between polymorphisms and TBI we hope to both inform the medical community about the potential for polymorphisms to influence recovery following TBI and provide a roadmap to researchers about the gaps in research within this population.
Export Options
About this article
Cite this article as:
Weaver M. Starla and Portelli N. Jaclyn, Neurobiological Influences on Recovery from Traumatic Brain Injury: The Role of Genetic Polymorphisms, Current Pharmaceutical Design 2014; 20 (26) . https://dx.doi.org/10.2174/13816128113196660657
DOI https://dx.doi.org/10.2174/13816128113196660657 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacokinetic Analysis of Tetramethylpyrazine Bis-Nitrone TN-2 in Rats and its Protein Binding In Vitro
Letters in Drug Design & Discovery Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review
Drug Delivery Letters Matrix Metalloproteinase Dependent Cleavage of Cell Adhesion Molecules in the Pathogenesis of CNS Dysfunction with HIV and Methamphetamine
Current HIV Research Physical Therapy Modalities in Management of Fibromyalgia
Current Pharmaceutical Design Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs
Current Pharmaceutical Design Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Chronic Thromboembolic Pulmonary Hypertension-Therapeutic Options
Current Respiratory Medicine Reviews Fibrates and Statins in the Treatment of Diabetic Retinopathy
Current Pharmaceutical Biotechnology ADF/Cofilin-Actin Rods in Neurodegenerative Diseases
Current Alzheimer Research Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Iodinated and Gadolinium Contrast Media in Computed Tomography (CT) and Magnetic Resonance (MR) Stroke Imaging
Current Medicinal Chemistry Adrenomedullin Expression in Alzheimer's Brain
Current Alzheimer Research Azelaic Acid: A Promising Agent for Dermatological Applications
Current Drug Therapy Neuroprotection & Mechanism of Ethanol in Stroke and Traumatic Brain Injury Therapy: New Prospects for an Ancient Drug
Current Drug Targets An Implantable Drug-delivery System on a Chip
Current Topics in Medicinal Chemistry Nanoemulsions for Skin Targeting: Present Status and Future Prospects
Drug Delivery Letters Cognitive Impairment with Vascular Impairment and Degeneration
Current Neurovascular Research Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator
Medicinal Chemistry Overview of Molecular Signal Transduction of Malignant Gliomas and Correlation with Responses to Targeted Therapy Recent advances in Molecular Characterization of Glioblastoma
Current Signal Transduction Therapy Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke
Current Medicinal Chemistry